Trials / Completed
CompletedNCT00371774
Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 426 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: To develop a real time national clinical database to support and share best practices, 1. To generate hypotheses for future clinical research 2. To understand how AMEVIVE is used in routine clinical practice/real world setting. Each patient visit will include the following observational endpoints: 1. AMEVIVE dosing 2. Number of courses 3. Concomitant treatment 4. Response to treatment (patient and physician global assessments) 5. Status of other psoriasis-related medical conditions 6. Time to re-treatment.
Conditions
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2006-09-04
- Last updated
- 2011-11-17
Locations
30 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00371774. Inclusion in this directory is not an endorsement.